STOCK TITAN

Verano Announces Upcoming Conference Participation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Verano Holdings Corp. (OTCQX: VRNOF), a leading multi-state cannabis company, has announced its participation in upcoming conferences. Key events include:

1. ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference on September 18, 2024, in New York, NY. Aaron Miles, Chief Investment Officer, will join investor meetings and a panel on Florida and other cannabis catalysts.

2. Benzinga Cannabis Capital Conference in Chicago, IL, on October 8-9, 2024. Multiple Verano executives will participate:

  • Darren Weiss, President, on a panel discussing life after 280E
  • George Archos, Founder, Chairman and CEO, in the Day 1 Closing Keynote Discussion
  • Julianna Paterra, VP of Investor Relations, on a panel about cannabis capital markets outlook for 2025

These events provide opportunities for Verano to share insights on industry trends and company strategies.

Verano Holdings Corp. (OTCQX: VRNOF), una delle principali aziende di cannabis multi-statali, ha annunciato la sua partecipazione a prossimi eventi. Gli eventi chiave includono:

1. ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference il 18 settembre 2024, a New York, NY. Aaron Miles, Chief Investment Officer, parteciperà a incontri con investitori e a un panel sui catalizzatori cannabici in Florida e altrove.

2. Benzinga Cannabis Capital Conference a Chicago, IL, l'8-9 ottobre 2024. Più dirigenti di Verano parteciperanno:

  • Darren Weiss, Presidente, in un panel che discute la vita dopo il 280E
  • George Archos, Fondatore, Presidente e CEO, nella discussione di apertura del Giorno 1
  • Julianna Paterra, VP delle Relazioni con gli Investitori, in un panel sulle prospettive del mercato dei capitali della cannabis per il 2025

Questi eventi offrono opportunità a Verano per condividere intuizioni sulle tendenze del settore e le strategie aziendali.

Verano Holdings Corp. (OTCQX: VRNOF), una destacada compañía de cannabis multiestatal, ha anunciado su participación en próximas conferencias. Los eventos clave incluyen:

1. ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference el 18 de septiembre de 2024, en Nueva York, NY. Aaron Miles, Director de Inversiones, participará en reuniones con inversores y en un panel sobre los catalizadores de cannabis en Florida y en otras partes.

2. Benzinga Cannabis Capital Conference en Chicago, IL, del 8 al 9 de octubre de 2024. Varios ejecutivos de Verano participarán:

  • Darren Weiss, Presidente, en un panel sobre la vida después del 280E
  • George Archos, Fundador, Presidente y CEO, en la discusión de apertura del Día 1
  • Julianna Paterra, VP de Relaciones con Inversores, en un panel sobre las perspectivas del mercado de capitales de cannabis para 2025

Estos eventos brindan oportunidades para que Verano comparta ideas sobre tendencias de la industria y estrategias empresariales.

Verano Holdings Corp. (OTCQX: VRNOF), 다수 주(州)에서 운영되는 선도적인 대마초 회사가 다가오는 컨퍼런스에 참여한다고 발표했습니다. 주요 이벤트는 다음과 같습니다:

1. ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference가 2024년 9월 18일 뉴욕에서 열립니다. Aaron Miles(투자 책임자)는 투자자 회의 및 플로리다와 기타 대마초 촉진 요인에 대한 패널에 참여합니다.

2. Benzinga Cannabis Capital Conference가 2024년 10월 8일과 9일 시카고에서 열립니다. 여러 Verano 임원들이 참여합니다:

  • Darren Weiss(회장), 280E 이후의 삶에 대한 패널에서
  • George Archos(설립자, 회장 및 CEO), 1일차 폐회 기조 발표에서
  • Julianna Paterra(투자자 관계 부사장), 2025년 대마초 자본 시장 전망에 대한 패널에서

이러한 이벤트는 Verano가 산업 동향 및 회사 전략에 대한 통찰력을 공유할 수 있는 기회를 제공합니다.

Verano Holdings Corp. (OTCQX: VRNOF), une société de cannabis multi-états de premier plan, a annoncé sa participation à des conférences à venir. Les événements clés comprennent :

1. ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference le 18 septembre 2024, à New York, NY. Aaron Miles, Directeur des Investissements, participera à des réunions avec des investisseurs et à un panel sur les catalyseurs cannabiques en Floride et ailleurs.

2. Benzinga Cannabis Capital Conference à Chicago, IL, les 8 et 9 octobre 2024. Plusieurs dirigeants de Verano participeront :

  • Darren Weiss, Président, lors d'un panel discutant de la vie après le 280E
  • George Archos, Fondateur, Président et CEO, lors de la discussion d'ouverture du Jour 1
  • Julianna Paterra, VP des Relations Investisseurs, lors d'un panel sur les perspectives des marchés de capitaux de cannabis pour 2025

Ces événements offrent à Verano l'occasion de partager des informations sur les tendances de l'industrie et les stratégies de l'entreprise.

Verano Holdings Corp. (OTCQX: VRNOF), ein führendes Unternehmen im Bereich Cannabis mit mehreren Bundesstaaten, hat seine Teilnahme an bevorstehenden Konferenzen angekündigt. Zu den wichtigsten Veranstaltungen gehören:

1. ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference am 18. September 2024 in New York, NY. Aaron Miles, Chief Investment Officer, wird an Investorenmeetings und einem Panel über den Cannabis-Katalysatoren in Florida und anderen Orten teilnehmen.

2. Benzinga Cannabis Capital Conference in Chicago, IL, am 8. und 9. Oktober 2024. Mehrere Führungskräfte von Verano werden daran teilnehmen:

  • Darren Weiss, Präsident, in einem Panel über das Leben nach dem 280E
  • George Archos, Gründer, Vorsitzender und CEO, in der Eröffnungskonferenz am ersten Tag
  • Julianna Paterra, VP für Investor Relations, in einem Panel zu den Aussichten des Cannabis-Kapitalmarkts für 2025

Diese Veranstaltungen bieten Verano die Möglichkeit, Einblicke in Branchentrends und Unternehmensstrategien zu teilen.

Positive
  • None.
Negative
  • None.

CHICAGO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the following conference participation:

ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference
Aaron Miles, Chief Investment Officer, will participate in 1x1 investor meetings and a panel titled Green Horizons: Florida and Other Upcoming Catalysts in Cannabis.
DATE: September 18, 2024
LOCATION: New York, NY
TIME: 12:00 p.m. ET

Benzinga Cannabis Capital Conference
Darren Weiss, President, will participate in a panel titled Life After 280E, Different Companies, Different Scenarios: More Money For All?
DATE: October 8, 2024
LOCATION: Chicago, IL
TIME: 9:40 a.m. CT

Benzinga Cannabis Capital Conference
George Archos, Founder, Chairman and Chief Executive Officer, will participate in the Day 1 Closing Keynote Discussion.
DATE: October 8, 2024
LOCATION: Chicago, IL
TIME: 4:50 p.m. CT

Benzinga Cannabis Capital Conference
Julianna Paterra, Vice President of Investor Relations, will participate in a panel titled Cannabis Capital Markets: What do the Industry’s Leading Operators Expect from 2025?
DATE: October 9, 2024
LOCATION: Chicago, IL
TIME: 10:00 a.m. CT

About Verano

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf and MÜV dispensary banners, including Cabbage Club, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano, (the) Essence, MÜV, Savvy, BITS, Encore, and Avexia. Verano’s active operations span 14 U.S. states, comprised of 15 production facilities with over 1,100,000 square feet of cultivation capacity. Learn more at Verano.com.
Contacts:

Media
Verano
Steve Mazeika
Vice President, Communications
Steve.Mazeika@verano.com
312-348-4430

Investors
Verano
Julianna Paterra, CFA
Vice President, Investor Relations
investors@verano.com

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q, in each case, filed with the U.S. Securities and Exchange Commission at www.sec.gov.The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
##


FAQ

When is Verano (VRNOF) participating in the ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference?

Verano (VRNOF) is participating in the ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference on September 18, 2024, in New York, NY.

Who from Verano (VRNOF) is speaking at the Benzinga Cannabis Capital Conference in October 2024?

Three Verano (VRNOF) executives are speaking at the Benzinga Cannabis Capital Conference: Darren Weiss (President), George Archos (Founder, Chairman and CEO), and Julianna Paterra (VP of Investor Relations).

What panel is Verano's (VRNOF) Chief Investment Officer participating in at the ATB Capital Markets conference?

Aaron Miles, Verano's (VRNOF) Chief Investment Officer, is participating in a panel titled 'Green Horizons: Florida and Other Upcoming Catalysts in Cannabis' at the ATB Capital Markets conference.

When and where is the Benzinga Cannabis Capital Conference that Verano (VRNOF) is attending in 2024?

The Benzinga Cannabis Capital Conference that Verano (VRNOF) is attending is on October 8-9, 2024, in Chicago, IL.

What topic will Verano's (VRNOF) President discuss at the Benzinga Cannabis Capital Conference?

Darren Weiss, Verano's (VRNOF) President, will participate in a panel titled 'Life After 280E, Different Companies, Different Scenarios: More Money For All?' at the Benzinga Cannabis Capital Conference.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

1.32B
259.21M
16.07%
11.02%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago